Novavax
NVAX
#4816
Rank
HK$16.50 B
Marketcap
HK$100.05
Share price
15.80%
Change (1 day)
54.34%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -HK$1.75 Billion

According to Novavax's latest financial reports the company's current earnings are HK$0.41 Billion. In 2025 the company made an earning of HK$3.64 Billion, an increase over its 2024 earnings that were of -HK$1.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.75 Billion-147.76%
2025 HK$3.64 B-396.87%
2024 -HK$1.23 Billion-70.39%
2023 -HK$4.15 Billion-16.59%
2022 -HK$4.98 Billion-62.58%
2021 -HK$13.3 Billion320.54%
2020 -HK$3.17 Billion234.22%
2019 -HK$0.95 Billion-30.17%
2018 -HK$1.36 Billion1.69%
2017 -HK$1.34 Billion-36.44%
2016 -HK$2.1 Billion70.4%
2015 -HK$1.23 Billion89.27%
2014 -HK$0.65 Billion59.83%
2013 -HK$0.41 Billion81.9%
2012 -HK$0.23 Billion50.33%
2011 -HK$0.15 Billion
2009 -HK$0.3 Billion8.8%
2008 -HK$0.27 Billion18.01%
2007 -HK$0.23 Billion18.33%
2006 -HK$0.2 Billion168.31%
2005 -HK$71.97 Million-62.51%
2004 -HK$0.2 Billion52.4%
2003 -HK$0.13 Billion-28.21%
2002 -HK$0.18 Billion
2000 -HK$99.99 Million177%
1999 -HK$36.1 Million-11.54%
1998 -HK$40.81 Million10.64%
1997 -HK$36.89 Million-9.62%
1996 -HK$40.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$121.80 B-7,047.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$54.20 B-3,191.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$112.46 B-6,514.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$61.91 B-3,631.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-HK$1.03 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.56 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$1.18 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-HK$63.5 Million-96.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$3 Billion 70.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$0.75 Billion-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA